AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 119 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,454,000 | +12.2% | 261,100 | -8.7% | 0.00% | – |
| Q2 2020 | $2,188,000 | +76.5% | 286,000 | +42.5% | 0.00% | – |
| Q1 2020 | $1,240,000 | -69.7% | 200,634 | -40.4% | 0.00% | -100.0% |
| Q4 2019 | $4,095,000 | -11.5% | 336,500 | -16.0% | 0.00% | 0.0% |
| Q3 2019 | $4,627,000 | -67.4% | 400,650 | -71.8% | 0.00% | -66.7% |
| Q2 2019 | $14,184,000 | +530.7% | 1,419,726 | +713.1% | 0.00% | +200.0% |
| Q1 2019 | $2,249,000 | +72.6% | 174,600 | +103.5% | 0.00% | – |
| Q4 2018 | $1,303,000 | -64.5% | 85,800 | -53.3% | 0.00% | -100.0% |
| Q3 2018 | $3,674,000 | -38.2% | 183,700 | -39.8% | 0.00% | -50.0% |
| Q2 2018 | $5,945,000 | -39.1% | 304,900 | -37.1% | 0.00% | -33.3% |
| Q1 2018 | $9,762,000 | +116.8% | 484,500 | +42.6% | 0.00% | +50.0% |
| Q4 2017 | $4,503,000 | -40.5% | 339,800 | -17.1% | 0.00% | -33.3% |
| Q3 2017 | $7,562,000 | -6.5% | 409,914 | -6.7% | 0.00% | 0.0% |
| Q2 2017 | $8,087,000 | -16.2% | 439,514 | +2.7% | 0.00% | -40.0% |
| Q1 2017 | $9,647,000 | +31.5% | 427,814 | +102.9% | 0.01% | +25.0% |
| Q4 2016 | $7,337,000 | -53.5% | 210,824 | -67.2% | 0.00% | -50.0% |
| Q3 2016 | $15,773,000 | +120.2% | 643,540 | +114.9% | 0.01% | +166.7% |
| Q2 2016 | $7,163,000 | +155.7% | 299,488 | +150.2% | 0.00% | +200.0% |
| Q1 2016 | $2,801,000 | -54.6% | 119,701 | -41.4% | 0.00% | -66.7% |
| Q4 2015 | $6,163,000 | +10.0% | 204,145 | +44.7% | 0.00% | +50.0% |
| Q3 2015 | $5,605,000 | -73.7% | 141,058 | -54.3% | 0.00% | -77.8% |
| Q2 2015 | $21,295,000 | +57.7% | 308,364 | +24.8% | 0.01% | +50.0% |
| Q1 2015 | $13,503,000 | +1239.6% | 247,039 | +944.3% | 0.01% | – |
| Q4 2014 | $1,008,000 | -7.1% | 23,655 | -30.4% | 0.00% | – |
| Q3 2014 | $1,085,000 | +55.4% | 34,000 | +1.0% | 0.00% | – |
| Q2 2014 | $698,000 | -37.2% | 33,680 | -41.4% | 0.00% | – |
| Q1 2014 | $1,112,000 | -3.3% | 57,500 | +7.5% | 0.00% | – |
| Q3 2013 | $1,150,000 | +43.6% | 53,500 | +48.6% | 0.00% | – |
| Q2 2013 | $801,000 | – | 36,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |